Integer (NYSE:ITGR) Price Target Raised to $150.00

Integer (NYSE:ITGR) had its target price upped by analysts at Truist Financial from $145.00 to $150.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s price target would suggest a potential upside of 14.10% from the company’s current price.

Other equities analysts have also recently issued reports about the stock. Benchmark reissued a “buy” rating and issued a $130.00 target price on shares of Integer in a research note on Wednesday, October 2nd. Citigroup lifted their price objective on shares of Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research report on Tuesday, October 1st. Oppenheimer started coverage on shares of Integer in a research note on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 target price for the company. Finally, Bank of America boosted their price target on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $138.71.

Integer Stock Down 0.7 %

Integer stock opened at $131.46 on Monday. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. Integer has a 1-year low of $69.40 and a 1-year high of $133.52. The company has a fifty day simple moving average of $125.84 and a 200 day simple moving average of $120.34. The company has a market cap of $4.40 billion, a P/E ratio of 45.49, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08.

Integer (NYSE:ITGR) last released its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The business had revenue of $436.20 million for the quarter, compared to the consensus estimate of $437.00 million. During the same quarter in the previous year, the business earned $1.14 earnings per share. Integer’s quarterly revenue was up 9.0% on a year-over-year basis. Research analysts anticipate that Integer will post 5.3 earnings per share for the current fiscal year.

Insider Buying and Selling at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total value of $1,431,133.60. Following the transaction, the director now owns 2,280 shares of the company’s stock, valued at approximately $272,824.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Integer

Several institutional investors and hedge funds have recently modified their holdings of ITGR. Vanguard Group Inc. increased its stake in Integer by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock worth $446,428,000 after acquiring an additional 23,382 shares during the period. Earnest Partners LLC raised its stake in Integer by 3.2% in the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after purchasing an additional 37,340 shares in the last quarter. Congress Asset Management Co. MA lifted its position in Integer by 7.5% during the first quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock worth $52,886,000 after purchasing an additional 31,736 shares during the period. Driehaus Capital Management LLC grew its stake in Integer by 62.5% during the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock worth $40,880,000 after buying an additional 135,750 shares in the last quarter. Finally, Tributary Capital Management LLC increased its holdings in Integer by 0.3% in the 2nd quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock valued at $33,168,000 after buying an additional 772 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.